| Literature DB >> 32818208 |
Wei Guo, Fangzhao Ming, Yu Dong, Qian Zhang, Lian Liu, Ming Gao, Xiaoxia Zhang, Pingzheng Mo, Yong Feng, Weiming Tang, Ke Liang.
Abstract
Background: Even people living with HIV/AIDS (PLWHA) were considered to be at increased risk of SARS-CoV-2 infection, the driving force among this group of individuals is still not clear. Methods : We investigated 1,701 PLWHA through a telephone interview and found 11 COVID-19 patients in four districts of Wuhan, China. The demographic features and major clinical characteristics of these patients were retrieved from the information management systems for COVID-19 patients of four districts' CDC. Statistical analysis was performed to find out the driving force of COVID-19 among PLWHA. Results : The incidence proportion of COVID-19 in PLWHA is 0.6% (95% CI: 0.2% - 1.0%), which is comparable to the overall population incidence rate in Wuhan city (0.6%). Nine out of the 11 COVID-19/AIDS patients had relatively high CD4+ T lymphocyte count (>200/μl) and undetectable HIV viral load (<20 copies/ml), and ten of them were on antiretroviral therapy. PLWHA who were old, had low CD4+ T lymphocyte count, infected HIV through homosexual activity, and had been diagnosed for HIV for a long time, were more likely to develop COVID-19. Conclusions: PLWHA has comparable COVID-19 morbidity rates as the general population, and older age, low CD4 count, long length since HIV diagnosis, and treatment-naive were potential driving forces of COVID-19 occurrence among PLWHA. Strategies in preventing SARS-CoV-2 infection among PLWHA with worse immune responses are needed. Article Summary Line: As COVID-19 continues to spread around the world, people living with HIV/AIDS (PLWHA) are also at risk of infection with SARS-CoV-2. We investigated the factors associated with SARS-CoV-2 infection among PLWHA in Wuhan, China.Entities:
Year: 2020 PMID: 32818208 PMCID: PMC7430583 DOI: 10.21203/rs.3.rs-53351/v1
Source DB: PubMed Journal: Res Sq
Figure 1The distribution of patients with COVID-19 and patients with HIV/AIDS in four districts, Wuhan. The distribution of all documented, laboratory-confirmed cases of coronavirus disease 2019 (COVID-19), and all documented patients with HIV/AIDS in Wuchang, Qingshan, Caidian and Xinzhou n districts, Wuhan was shown in the figure, according to the official management system of Center for Disease Control and Prevention of Hubei province by May 14,2020. Note: The designations employed and the presentation of the material on this map do not imply the expression of any opinion whatsoever on the part of Research Square concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. This map has been provided by the authors.
Social-demographic and status of people living with HIV in Wuhan, China, 2020 (N=1701)
| Total enrolled HIV/AIDS (n=1701) | COVID-19 (n=11) | Without COVID-19 (n=1690) | |
|---|---|---|---|
| Age | 42.0±14.5 | 53.2±12.8 | 42.0±14.5 |
| Gender | |||
| | 1484(87.2%) | 10 (90.9%) | 1474(87.2%) |
| | 217 (12.8%) | 1 (9.1%) | 216 (12.8%) |
| Marriage status | |||
| | 416 (24.5%) | 4 (36.4%) | 412 (24.4%) |
| | 854 (50.2%) | 4 (36.4%) | 850 (50.3%) |
| | 431 (25.3%) | 3 (27.3%) | 428 (25.3%) |
| Transmission route | |||
| 1173 (69.0%) | 10 (90.9%) | 1163 (68.8%) | |
| | 495 (29.1%) | 1 (9.1%) | 494 (29.2%) |
| | 33 (1.9%) | 0 (0.0%) | 33 (2.0%) |
| Log10(CD4) | 2.63±0.31 | 2.50±0.42 | 2.63±0.31 |
| Log10(VL) | 0.89±1.62 | 0.41±1.37 | 0.89±1.62 |
| Days diagnosed/100 | 16.8±11.8 | 27.4±11.4 | 16.8±11.7 |
| Days ART/100 | 14.5±10.4 | 20.3±10.4 | 14.5±10.4 |
| ART regimen | |||
| | 1406(82.7%) | 9 (81.8%) | 1397(82.7%) |
| | 172 (10.1%) | 1 (9.1%) | 171 (10.1%) |
| 87 (5.1%) | 0 (0.0%) | 87 (5.1%) | |
| | 36 (2.1%) | 1 (9.1%) | 35 (2.1%) |
Note:
Most recent, INI: integrase inhibitors; INI-based: 62 Dolutegravir-based, 19 Elvitegravir/Cobicista-based, 4 Raltegravir-based, 2 Bictegravir-based.
Factors associate with COVID-19 occurrence among people living with HIV in Wuhan, China, 2020 (N=1701)
| Univariable Firth’s Logistic Regression | P | Multivariable Firth’s Logistic Regression | P | |
|---|---|---|---|---|
| Age | 1.05 (1.01, 1.09) | 0.012 | 1.07 (1.02, 1.13) | 0.010 |
| Gender | ||||
| Male | 1 | 1 | ||
| Female | 0.97 (0.17, 5.44) | 0.975 | 3.00 (0.17, 52.01) | 0.451 |
| Marriage status | ||||
| | 1 | 1 | ||
| | 0.49 (0.13, 1.80) | 0.280 | 0.96 (0.17, 5.23) | 0.958 |
| Widow | 0.75 (0.18, 3.05) | 0.687 | 0.51 (0.14, 1.87) | 0.312 |
| Transmission route | ||||
| 1 | 1 | |||
| | 0.34 (0.06, 1.87) | 0.213 | 0.07 (0.01, 0.90) | 0.042 |
| | 1.65 (0.09, 30.02) | 0.734 | 0.003 (<0.001, 0.85) | 0.044 |
| Log10(CD4) | 0.34 (0.12, 0.97) | 0.044 | 0.06 (0.01, 0.30) | <0.001 |
| Log10(VL) | 0.86 (0.55, 1.33) | 0.486 | 0.62 (0.33, 1.16) | 0.133 |
| Days diagnosed/100 | 1.06 (1.02, 1.10) | 0.002 | 1.12 (1.05, 1.19) | <0.001 |
| Days ART/100 | 1.05 (1.00, 1.09) | 0.040 | 0.97 (0.90, 1.04) | 0.318 |
| ART regimen | ||||
| | 1 | 1 | ||
| | 1.29 (0.23, 7.28) | 0.776 | 1.25 (0.25, 6.29) | 0.786 |
| | 0.84 (0.05, 14.79) | 0.906 | 1.84 (0.12, 29.37) | 0.666 |
| | 6.22 (1.05, 36.68) | 0.044 | 13.36 (0.77, 231.74) | 0.075 |
Note: OR=odds ratio, AOR=adjusted odds ratio, CI=confidence interval;
Most recent testing.